Table 2.

Non-weighted proportional hazard models for the risk of cutaneous and anogenital verrucae among the 1,790 HIV-infected women in the WIHS.

Cutaneous verrucae	With CCH* use								Without CCH* Drug Use
Variable		Lower	Upper	P-		Lower	Upper	P-		Lower	Upper	P-
	RH	CI	CI	value	RH	CI	CI	value	RH	CI	CI	value
Cohort (ref=01/02 Cohort)	2.12	0.74	6.11	0.165	2.13	0.74	6.14	0.161	2.31	0.80	6.68	0.124
Age at baseline, 10 year increase	1.25	0.91	1.72	0.169	1.26	0.92	1.72	0.143	1.27	0.94	1.72	0.126
Black (ref=white)	0.50	0.29	0.86	0.012	0.49	0.28	0.84	0.009	0.53	0.31	0.91	0.021
Hispanic	0.38	0.19	0.74	0.005	0.37	0.19	0.74	0.004	0.38	0.19	0.75	0.005
HPV infection at baseline	1.23	0.74	2.05	0.415	1.23	0.74	2.04	0.432	1.27	0.76	2.09	0.361
Lifetime number of sex partners at baseline (ref=0-4 partners)
5-10 partners	0.93	0.47	1.86	0.846	0.94	0.47	1.86	0.857	0.89	0.45	1.76	0.738
11-50 partners	1.08	0.58	2.00	0.815	1.07	0.57	1.98	0.844	1.02	0.56	1.88	0.941
51+ partners	0.96	0.46	2.02	0.912	0.95	0.45	2.02	0.902	0.94	0.45	1.99	0.878
Current smoker	0.67	0.38	1.17	0.158	0.68	0.39	1.19	0.178	0.78	0.48	1.28	0.326
1 Hospitalization, prior visit (ref=0)	0.70	0.32	1.56	0.382	0.70	0.32	1.57	0.390	0.69	0.31	1.52	0.356
2+ Hospitalization, prior visit	0.63	0.15	2.62	0.527	0.63	0.15	2.64	0.529	0.62	0.15	2.54	0.501
Developed AIDS by visit	0.95	0.59	1.55	0.841	0.97	0.60	1.56	0.888	1.03	0.64	1.66	0.916
Initiated HAART	1.14	0.65	1.99	0.650	1.13	0.65	1.97	0.676	1.18	0.67	2.07	0.577
Lowest CD4, past 4 years (per 100 cells)	1.18	0.92	1.50	0.192	1.18	0.92	1.51	0.186	1.19	0.94	1.52	0.150
CD4 count, prior visit (per 100 cells)	0.87	0.73	1.04	0.127	0.87	0.73	1.04	0.126	0.87	0.73	1.03	0.113
Highest Log10 VL, past 4 years	0.98	0.72	1.34	0.896	0.98	0.72	1.35	0.907	0.97	0.71	1.32	0.829
Log10 HIV RNA, prior visit	1.09	0.83	1.43	0.538	1.09	0.83	1.43	0.547	1.10	0.84	1.44	0.490
Use of CCH*, past 4 years	1.84	0.93	3.62	0.078	1.93	1.01	3.66	0.045
Use of CCH*, prior visit	0.38	0.12	1.23	0.106	0.50	0.20	1.22	0.129
IDU, past 4 years	1.18	0.47	2.98	0.724
IDU, prior visit	1.85	0.40	8.60	0.431

Anogenital verrucae	With CCH* use								Without CCH* Drug Use
Variable	RH	Lower CI	Upper CI	P- value	RH	Lower CI	Upper CI	P- value	RH	Lower CI	Upper CI	P- value
Cohort (ref=01/02 Cohort)	0.63	0.44	0.89	0.009	0.63	0.44	0.89	0.008	0.62	0.44	0.88	0.007
Age at baseline, 10 year increase	0.82	0.71	0.96	0.010	0.82	0.71	0.95	0.009	0.83	0.71	0.96	0.011
Black (ref=white)	1.27	0.89	1.80	0.182	1.28	0.90	1.81	0.169	1.27	0.90	1.80	0.171
Hispanic	1.15	0.78	1.69	0.482	1.17	0.80	1.72	0.425	1.17	0.80	1.72	0.423
HPV+ at baseline	1.85	1.42	2.40	<.001	1.85	1.42	2.40	<.001	1.83	1.41	2.37	<.001
Lifetime number of sex partners at baseline (ref=0-4 partners)
5-10 partners	0.94	0.68	1.32	0.736	0.95	0.68	1.32	0.738	0.95	0.68	1.32	0.759
11-50 partners	0.86	0.63	1.19	0.370	0.87	0.63	1.19	0.380	0.88	0.64	1.21	0.431
51+ partners	1.34	0.97	1.84	0.077	1.36	0.99	1.87	0.059	1.41	1.03	1.93	0.034
Current smoker	1.40	1.08	1.81	0.012	1.39	1.08	1.81	0.012	1.40	1.10	1.80	0.008
1 Hospitalization, prior visit (ref=0)	1.33	0.99	1.79	0.055	1.32	0.99	1.78	0.061	1.33	0.99	1.79	0.058
2+ Hospitalization, prior visit	0.97	0.56	1.71	0.928	0.96	0.54	1.68	0.874	0.95	0.54	1.67	0.868
Developed AIDS by visit	1.26	0.98	1.61	0.072	1.26	0.98	1.62	0.070	1.26	0.98	1.62	0.069
Initiated HAART	1.11	0.85	1.44	0.445	1.10	0.85	1.43	0.473	1.08	0.83	1.40	0.561
Lowest CD4, past 4 years (per 100 cells)	0.85	0.77	0.95	0.002	0.85	0.77	0.94	0.002	0.85	0.77	0.95	0.003
CD4 count, prior visit (per 100 cells)	1.01	0.94	1.08	0.865	1.01	0.94	1.08	0.854	1.00	0.94	1.08	0.917
Highest Log10 VL, past 4 years	0.95	0.80	1.13	0.539	0.95	0.80	1.13	0.587	0.95	0.80	1.13	0.587
Log10 HIV RNA, prior visit	1.34	1.16	1.56	<.001	1.34	1.16	1.55	<.001	1.34	1.15	1.54	<.001
Use of CCH*, past 4 years	0.98	0.68	1.41	0.904	0.96	0.69	1.35	0.832
Use of CCH*, prior visit	1.19	0.76	1.85	0.444	1.16	0.77	1.73	0.485
IDU, past 4 years	0.97	0.56	1.66	0.907
IDU, prior visit	0.83	0.37	1.86	0.657

^*CCH = crack, cocaine, or heroin use